Chloro-orienticin C
| Internal ID | 6d7e081c-26d0-40f3-9174-6e53015eb1d3 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | (2R,18R,19R,22S,25R,40S)-2-(4-amino-5-hydroxy-4,6-dimethyloxan-2-yl)oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-18,32,35,37,48-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8,10,12(48),14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C60H65Cl2N9O19/c1-22(2)12-33(65-5)53(79)70-47-49(76)25-7-10-37(31(61)14-25)88-39-16-27-17-40(50(39)77)89-38-11-8-26(15-32(38)62)51(90-42-21-60(4,64)52(78)23(3)87-42)48-58(84)69-46(59(85)86)30-18-28(72)19-36(74)43(30)29-13-24(6-9-35(29)73)44(55(81)71-48)68-56(82)45(27)67-54(80)34(20-41(63)75)66-57(47)83/h6-11,13-19,22-23,33-34,42,44-49,51-52,65,72-74,76-78H,12,20-21,64H2,1-5H3,(H2,63,75)(H,66,83)(H,67,80)(H,68,82)(H,69,84)(H,70,79)(H,71,81)(H,85,86)/t23?,33-,34+,42?,44?,45-,46+,47-,48?,49-,51-,52?,60?/m1/s1 |
| InChI Key | CHSINQSLUWRGER-YGSFPILTSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C60H65Cl2N9O19 |
| Molecular Weight | 1287.10 g/mol |
| Exact Mass | 1285.3773763 g/mol |
| Topological Polar Surface Area (TPSA) | 451.00 Ų |
| XlogP | -0.80 |
| Atomic LogP (AlogP) | 2.63 |
| H-Bond Acceptor | 20 |
| H-Bond Donor | 16 |
| Rotatable Bonds | 10 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8211 | 82.11% |
| Caco-2 | - | 0.8612 | 86.12% |
| Blood Brain Barrier | - | 0.8500 | 85.00% |
| Human oral bioavailability | - | 0.8429 | 84.29% |
| Subcellular localzation | Lysosomes | 0.4606 | 46.06% |
| OATP2B1 inhibitior | - | 0.7247 | 72.47% |
| OATP1B1 inhibitior | + | 0.8888 | 88.88% |
| OATP1B3 inhibitior | + | 0.9394 | 93.94% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.9318 | 93.18% |
| BSEP inhibitior | + | 0.9609 | 96.09% |
| P-glycoprotein inhibitior | + | 0.7420 | 74.20% |
| P-glycoprotein substrate | + | 0.8511 | 85.11% |
| CYP3A4 substrate | + | 0.7559 | 75.59% |
| CYP2C9 substrate | - | 0.7979 | 79.79% |
| CYP2D6 substrate | - | 0.8229 | 82.29% |
| CYP3A4 inhibition | - | 0.8018 | 80.18% |
| CYP2C9 inhibition | - | 0.8766 | 87.66% |
| CYP2C19 inhibition | - | 0.8564 | 85.64% |
| CYP2D6 inhibition | - | 0.9142 | 91.42% |
| CYP1A2 inhibition | - | 0.8329 | 83.29% |
| CYP2C8 inhibition | + | 0.8439 | 84.39% |
| CYP inhibitory promiscuity | - | 0.7083 | 70.83% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.7800 | 78.00% |
| Carcinogenicity (trinary) | Non-required | 0.4453 | 44.53% |
| Eye corrosion | - | 0.9858 | 98.58% |
| Eye irritation | - | 0.8972 | 89.72% |
| Skin irritation | - | 0.7825 | 78.25% |
| Skin corrosion | - | 0.9290 | 92.90% |
| Ames mutagenesis | - | 0.5400 | 54.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7278 | 72.78% |
| Micronuclear | + | 0.8000 | 80.00% |
| Hepatotoxicity | + | 0.6375 | 63.75% |
| skin sensitisation | - | 0.8548 | 85.48% |
| Respiratory toxicity | + | 0.8778 | 87.78% |
| Reproductive toxicity | + | 0.8889 | 88.89% |
| Mitochondrial toxicity | + | 0.8125 | 81.25% |
| Nephrotoxicity | - | 0.6299 | 62.99% |
| Acute Oral Toxicity (c) | III | 0.6021 | 60.21% |
| Estrogen receptor binding | + | 0.7447 | 74.47% |
| Androgen receptor binding | + | 0.7793 | 77.93% |
| Thyroid receptor binding | + | 0.6909 | 69.09% |
| Glucocorticoid receptor binding | + | 0.7303 | 73.03% |
| Aromatase binding | + | 0.6596 | 65.96% |
| PPAR gamma | + | 0.7963 | 79.63% |
| Honey bee toxicity | - | 0.6436 | 64.36% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.6005 | 60.05% |
| Fish aquatic toxicity | + | 0.8998 | 89.98% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.85% | 91.11% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.58% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.02% | 96.09% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.34% | 94.45% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 97.59% | 97.09% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 97.47% | 99.15% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 96.39% | 90.00% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 96.01% | 96.38% |
| CHEMBL3837 | P07711 | Cathepsin L | 95.75% | 96.61% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 94.16% | 86.33% |
| CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 92.92% | 97.31% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 92.37% | 89.00% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 91.91% | 96.21% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 91.65% | 95.89% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.43% | 95.56% |
| CHEMBL236 | P41143 | Delta opioid receptor | 91.13% | 99.35% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 90.95% | 90.17% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 90.91% | 89.50% |
| CHEMBL1951 | P21397 | Monoamine oxidase A | 90.78% | 91.49% |
| CHEMBL2335 | P42785 | Lysosomal Pro-X carboxypeptidase | 90.74% | 100.00% |
| CHEMBL222 | P23975 | Norepinephrine transporter | 90.65% | 96.06% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 90.63% | 85.11% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 90.17% | 91.19% |
| CHEMBL2083 | P15090 | Fatty acid binding protein adipocyte | 90.09% | 95.71% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 89.75% | 85.00% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 89.53% | 96.11% |
| CHEMBL2243 | O00519 | Anandamide amidohydrolase | 89.09% | 97.53% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 88.93% | 92.32% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 86.58% | 99.17% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 85.84% | 96.47% |
| CHEMBL242 | Q92731 | Estrogen receptor beta | 85.26% | 98.35% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 85.12% | 92.29% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 84.73% | 97.14% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 83.61% | 96.25% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 83.29% | 85.31% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 82.96% | 80.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 82.68% | 90.71% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 81.96% | 93.56% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 81.84% | 95.50% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 81.74% | 97.33% |
| CHEMBL268 | P43235 | Cathepsin K | 81.56% | 96.85% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 81.15% | 94.73% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 80.77% | 96.95% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 80.76% | 89.62% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 80.36% | 96.90% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139587402 |
| LOTUS | LTS0104074 |
| wikiData | Q77565275 |